Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.8212
+0.0316 (4.00%)
At close: Jul 24, 2026, 4:00 PM EDT
0.8400
+0.0188 (2.29%)
Pre-market: Jul 27, 2026, 7:12 AM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $3.03 million as of July 27, 2026. Its market cap has increased by 55.32% in one year.
Market Cap
3.03M
Enterprise Value
-394.70K
1-Year Change
55.32%
Ranking
Category
Stock Price
$0.82
ChartMarket Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $3.03M, a decrease of -99.51%. That is a compound annual growth rate of -69.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.03M | 24.97% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 3.76M |
| Artelo Biosciences | 3.56M |
| Galmed Pharmaceuticals | 3.38M |
| Propanc Biopharma | 3.12M |
| SciSparc | 3.06M |
| Creative Medical Technology Holdings | 3.00M |
| HCW Biologics | 2.98M |
| Decoy Therapeutics | 2.68M |